TARGIMMUNE THERAPEUTICS
TargImmune Therapeutics AG is a private Swiss-based biotechnology company focused on drug development using novel targeted onco-immunotherapies. The Company’s principal technology is the CTPIC technology platform that utilizes a non-viral vector to target and destroy cancer cells that over-express certain receptors while simultaneously eliciting an immune response against the cancer cells.
TARGIMMUNE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.targimmune.com
Total Employee:
1+
Status:
Active
Contact:
+41 61 225 1926
Email Addresses:
[email protected]
Total Funding:
19.35 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Nuxt.js
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
CimCure
CimCure focuses on design and development of a novel class of active cancer immunotherapies.
CymaBay Therapeutics
CymaBay Therapeutics is focused on the development and commercialization of proprietary new medicines for critical human diseases.
Devon Labs
Devon Labs solve patients unmet medical and care needs.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - TargImmune Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-07 | TargImmune Announces Another Senior Hire as Veronica Hersberger Revealed As New Chief Medical Officer |
| 2021-07-18 | TargImmune raises CHF17.7 million and appoints new CEO |
Official Site Inspections
http://www.targimmune.com
- Host name: 104.248.175.226
- IP address: 104.248.175.226
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "TargImmune Therapeutics"
TargImmune Therapeutics - Crunchbase Company …
TargImmune Therapeutics AG is a private Swiss-based biotechnology company focused on drug development using novel targeted onco-immunotherapies. …See details»
Our Platform - TargImmune
TargImmune’s proprietary, first-in-class targeted nucleic acid delivery platform uses a synthetic nanoparticle to systemically deliver interchangeable nucleic acid therapeutics directly on target. This unique technology and innovative …See details»
TargImmune Therapeutics AG - LinkedIn
TargImmune Therapeutics AG is a private Swiss-based biotechnology company developing a novel targeted cancer treatment modality. TargImmune has a unique dsRNA non-viral vector delivery platform ...See details»
iOncologi - Home Page
TargImmune Therapeutics is developing a first-in-class, receptor-targeted non-viral RNA delivery platform. Its lead program, IONC201, is an IND-ready biologic that achieves effective EGF …See details»
Media & Investors - TargImmune
TargImmune successfully closed its 2021 financing round and appoints Peter Braun as Chief Executive Officer. Basel, Switzerland, 09/07/2021 TargImmune Therapeutics AG (Basel, Switzerland), a privately held Swiss-based …See details»
TargImmune Therapeutics - Swiss Biotech
TargImmune Therapeutics AG is a private Swiss-based biotechnology company focused on drug development using novel targeted onco-immunotherapies. ... Location. Hochbergerstrasse 60C, 4057 Basel, Switzerland. Get Directions …See details»
TargImmune Therapeutics - Contacts, Employees, Board Members, …
Organization. TargImmune Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Contacts 3. About. TargImmune Therapeutics has 5 current …See details»
TargImmune Therapeutics AG Information - RocketReach
TargImmune has a unique dsRNA non-viral vector delivery platform which, by mimicking a virus, harnesses the body's powerful antiviral defenses to address cancer tumors including distant …See details»
iOncologi Acquires TargImmune Therapeutics | Contract Pharma
Mar 17, 2025 As part of the transaction, iOncologi, Inc. and TargImmune Therapeutics executed a share purchase agreement, resulting in iOncologi acquiring at least 99% of TargImmune’s …See details»
TargImmune Therapeutics - VentureRadar
At TargImmune, our mission is to significantly improve the survival of cancer patients. Our novel Ta:RNA™ platform produces modular and flexible targeted nanoparticles - a new modality and …See details»
TargImmune Therapeutics AG - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TargImmune Therapeutics AG of Basel, BASEL-STADT. Get the latest business insights from Dun & …See details»
TargImmune Therapeutics AG - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... TargImmune Therapeutics AG, …See details»
TargImmune Therapeutics - News, Mergers and Acquisitions, …
TargImmune Therapeutics is a biotechnology company specializing in novel tumor-targeted immunotherapies. iOncologi's acquisition of TargImmune enhances its capabilities in …See details»
TargImmune Therapeutics - Overview, News & Similar companies
Feb 7, 2022 TargImmune Therapeutics AG is a privately owned Swiss-based biotechnology company based in Basel and founded in 2016. TargImmune is dedicated to significantly …See details»
Contact - TargImmune
The TargImmune offices and laboratories are located in the Technology Park Basel. Hochbergerstrasse 60C. 4057 Basel. Switzerland +41 61 551 45 00. [email protected]. …See details»
TargImmune Therapeutics gets acquired - startupticker.ch
Mar 20, 2025 As TargImmune’s lead targeted apoptosis and immune modulator (TAIM) therapy, TAR001 has the potential to be applied to a wide range of cancers and change the lives of a …See details»
Targimmune Therapeutics AG (Targimmune Therapeutics AG) - 药 …
6 days ago About TargImmune Therapeutics TargImmune Therapeutics is a biotechnology company developing targeted immunotherapy solutions designed to enhance anti-tumor …See details»
Our Pipeline - TargImmune
TargImmune is on track to file an Investigational New Drug Application (IND) / Clinical Trial Application (CTA) with subsequent entry into man in first half of 2024. TAR001 has the …See details»
BCG Revaccination for the Prevention of Mycobacterium …
5 days ago A total of 1836 participants underwent randomization; 918 received the BCG vaccine, and 917 received placebo. After a median 30 months of follow-up, a sustained QFT …See details»
TargImmune Announces Successful Completion of GLP/Tox …
Jul 6, 2022 TargImmune Therapeutics AG, a privately owned Swiss-based biotechnology company dedicated to significantly improving the survival of cancer patients with their first-in …See details»